Europe Cryotherapy And Cryosurgery Market

Europe Cryotherapy and Cryosurgery Market Size & Growth (2023 to 2028)

The Size of the Europe Cryotherapy and Cryosurgery Market is valued at USD 0.84 billion in 2023. It is expected to grow at a CAGR of 6.4%, reaching USD 1.15 billion by 2028 during the forecast period 2023 to 2028.

The introduction of vacuum flasks for storing liquid nitrogen effectively has enhanced cryosurgery and cryotherapy applications. Furthermore, technical advancements and medical research evaluating the potential of cryotherapy and cryosurgery in treating different disorders would boost Europe's market demand soon. Cryosurgery is generally accepted for its potential benefits in curing many diseases by immersing the body in liquid nitrogen in cryo chambers or cryo saunas.

Compared to open surgery and other treatments, one of the primary growth factors for the cryotherapy and cryosurgery market is the minimal post-surgery danger to untargeted body parts and more minor wounds and suffering. Furthermore, the growing preference for invasive procedures, and an increase in cryotherapy treatment applications, such as cardiac conditions, pain management, skin disorders, beauty, wellness, and fitness, are expected to propel the market forward.

The benefits of combining cryosurgical techniques with radiation, chemotherapy, and hormone therapy are driving market expansion. Cryosurgery treatment may be used internally and externally, allowing it to treat skin conditions and boost the market growth. Reducing several adverse effects due to localized and limited treatment is another market-driving factor. Increasing product launches, low-cost cryotherapy devices, and rising cryotherapy device use are projected to drive market growth throughout the forecast period.

The expensive cost of treatment, strict safety rules, adverse effects connected with cryogenic gasses, lack of complete information on cryotherapy, and the complexity of cryotherapy mechanisms are likely to hamper the business. In addition, because of the uncontrolled freezing during cryotherapy treatments, nearby tissue, bones, and muscle may go numb.

Furthermore, prolonged exposure to the freezing liquid nitrogen can be fatal, so medical professionals have advised against using it on youngsters, those with high blood pressure, or pregnant women; despite the market challenges posed by all these disadvantages, ongoing medical research and technological advancements in this market promise a long-term and unparalleled market revenue and demand.

Furthermore, due to their rapid growth, combustible gasses such as methane, hydrogen, carbon monoxide, and liquefied natural gas can cause problems such as fire and explosion. As a result, safety concerns about cryotherapy gasses are expected to hamper Europe's market growth.

This research report on the Europe Cryotherapy and Cryosurgery Market has been segmented and sub-segmented into the following categories.

By Technique: 

• Spray
• Forceps
• CryoProbe

By Type:

• Cryosurgery
• Icepack Therapy
• Cryogenic Chamber Therapy

By Application:

• Cancer Therapy
• Skin Disease
• Others

By Device:

• Cryogun
• Probes
• Cryogen
• Others

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, Europe has the largest market share and is expected to develop significantly and continue to dominate the global cryotherapy and cryosurgery market throughout the forecast period. Due to expanding awareness and the rising occurrences of cancer and skin problems, Europe has overtaken North America's revenue contribution.

The U.K cryotherapy and cryosurgery market will continue to increase as healthcare infrastructure improves and trained healthcare providers become more readily available. The region's large proportion can be attributed to its well-established healthcare infrastructure, favorable reimbursement conditions, and widespread usage of technologically advanced therapies.

The Spain cryotherapy and cryosurgery market is estimated to reach a decent CAGR over the forecast period. Furthermore, significant enterprises' local presence and continuous strategic efforts are likely to aid regional development. In December 2019, European health officials approved using CSA Medical's cryotherapy system to treat chronic bronchitis in COPD (chronic obstructive pulmonary disease) patients.

KEY MARKET PLAYERS

Prominent Companies leading the Europe Cryotherapy and Cryosurgery Market Profiled in the Report are Erbe, Incorporated, MedGyn Products, Inc. and CoolTouch Inc, HealthTronics, Inc., KryoLife Inc, Medtronic, GRAND Cryo LLC, Impact Cryotherapy, Galil Medical Inc, Wallach Surgical Devices.,